Green Planet Bioengineering Co Ltd (GPLB)

[jmurfk]

This is a very nice one. EPS of .27 on the annual and a nickel on the quarterly.

[AliAngel]

Still agreat buy and hold for sure Julian.
dave

Green Planet Bioengineering Co., Ltd.
Consolidated Statements of Income and Comprehensive Income
(Unaudited)
(Stated in US dollars)

Three months ended March 31,
2010 2009

Sales revenue $ 3,259,429 $ 2,297,621
Cost of sales (1,469,280 ) (852,686 )

Gross profit 1,790,149 1,444,935

Operating expenses
Administrative expenses 321,799 212,215
Research and development expenses 60,388 36,466
Selling expenses 174,311 56,031

556,498 304,712

Income from operations 1,233,651 1,140,223
Interest income 1,569 249
Other income 90 -
Finance costs (36,709 ) (88 )

Income before income taxes 1,198,601 1,140,384
Income taxes (253,853 ) (297,659 )

Net income $ 944,748 $ 842,725

Other comprehensive income (loss)
Foreign currency translation adjustments 618 (19,500 )

Total comprehensive income $ 945,366 $ 823,225

Earnings per share
- Basic $ 0.05 $ 0.05

- Diluted $ 0.04 $ 0.04

Weighted average number of shares outstanding :
- Basic 20,006,402 15,407,725

- Diluted 25,260,001 19,951,204

See Notes to Condensed Consolidated Financial Statements



F-4
--------------------------------------------------------------------------------



Green Planet Bioengineering Co., Ltd.
Consolidated Balance Sheets
(Stated in US dollars)

March 31, 2010 December 31, 2009
(Unaudited) (Audited)
ASSETS
Current assets
Cash and cash equivalents $ 4,228,840 $ 791,775
Trade receivables 3,395,745 5,078,734
Deferred taxes 85,492 76,772
Prepaid expenses and other receivables 1,029,674 820,288
Inventories 1,579,171 1,203,490
Prepayments of operating lease 1,711,130 1,711,130

Total current assets 12,030,052 9,682,189
Intangible assets 655,138 681,315
Deposit for acquisition of intangible assets 161,153 161,151
Property, plant and equipment, net 3,648,968 3,507,538
Land use rights 994,830 1,000,428
Deferred taxes 22,770 22,770
Available for sale securities 5,000,000 5,000,000
Prepayments of operating lease 7,341,289 7,790,914

TOTAL ASSETS $ 29,854,200 $ 27,846,305

LIABILITIES AND STOCKHOLDERS’ EQUITY

LIABILITIES
Current liabilities
Trade payables $ 241,501 $ 557,155
Other payables and accrued expenses 437,014 541,371
Amount due to a related party 17,317 16,189
Amount due to a stockholder 42,236 34,528
Deferred taxes 173,663 148,581
Secured loans from a financial institution 1,860,588 1,860,561
Convertible loan payable 190,000 190,000
Short term loans payable 1,800,000 -
Income tax payable 260,429 611,745
Deferred revenue 62,996 62,995

Total current liabilities 5,085,744 4,023,125

TOTAL LIABILITIES 5,085,744 4,023,125

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS’ EQUITY
Preferred stock : par value of $0.001 per share, Authorized: 10,000,000 shares as of March 31, 2010 and December 2009, 5,101 shares issued and outstanding as of March 31, 2010 and December 2009. 5 5
Common stock : par value $0.001 per share 250,000,000 shares authorized; 20,006,402 shares issued and outstanding as of March 31, 2010 and December 31, 2009 20,006 20,006
Additional paid-in capital 10,293,896 10,293,896
Statutory reserve 1,305,895 1,305,895
Accumulated other comprehensive income 1,459,595 1,458,976
Retained earnings 11,689,059 10,744,402

TOTAL STOCKHOLDERS’ EQUITY 24,768,456 23,823,180


TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 29,854,200 $ 27,846,305

[jmurfk]

Similar OS, and each filed their 10-Ks at the end of March this year.

GPLB(.53) w/ .27 EPS diluted

ONBI($6) w/ .16 EPS diluted

GPLB is so undervalued, lol.

[AUminer]

What's the Best Play here Murph? The GPLB or the ONBI?

By the way, Did You see the 60 Minutes Story on the Oil Spill? Check out my Pubic Messages.

[jmurfk]

Seems GPLB doesn't release many PRs through the Marketwire or other service, but has the releases on its webpage.

[jmurfk]

News from GPLBs Website - New Product Expected to Deliver $8 Million in Revenue in 2010
Feb. 11, 2010 (U.S. Equity News) --

Green Planet (OTCBB: GPLB.OB), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced the addition of 8 new distributors to support the launch of the Company's Jinglao "King of Medicine" brand beverage crystals from Ganoderma Lucidum extracts.


Extracts from Ganoderma Lucidum are believed by Chinese medical professionals to be a valuable remedy for weight management, immunity boost, tumor prevention and to act as powerful antioxidants. Several books, including the one written by Dr. Shi-Jean Lee, a renowned Chinese medical professional, discuss the benefits associated with the long term use of Ganoderma Lucidum extracts.

"We have seen strong demand for our Jinglao brand since our launch. We sold over $300k in our first month and anticipate 2010 sales for Jinglao to reach in excess of $8 million. We strongly believe that the increase in the number of products in our over-the-counter portfolio will result in strong organic growth this year," stated ONE's CEO Marius Silvasan. "Over-the-counter health products are a lucrative segment in the marketplace. We believe that our focus on the development of these highly demanded and profitable products will contribute to our future success," added Mr. Silvasan,our mother company's CEO.


"To support distribution for Jinglao we added 8 new regional distributors in key markets along the east coast of China," stated ONE's China President Min Zhao. "We also see strong demand for Jinglao outside of China including the United States and other Asian countries. We intend to expand our distribution in those areas later this year," added Mr. Zhao.

[jmurfk]

Recent News(5/15/2010) from GPLBs Website - Green Planet Bioengineering Co., Ltd (GP) Sponsors a Major Health Product Tradeshow in New Jersey

Time:2010-05-15

ONE Bio, Corp. ("ONE") (OTC.BB:ONBI - News), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, announced that its subsidiary, Green Planet Bioengineering (“GP”) will be sponsoring and exhibiting in the SupplySide East, one of the largest US health product tradeshow.

The SupplySide East show is an informative, educational and connecting event that gathers thousands of health product suppliers, manufacturers and pharmaceutical leaders from all over the world, to meet, start and build relationships. In addition, the show provides networking tools and opportunities to GP and exhibitors prior to show date. “We are very excited to sponsor and exhibit in the show; this is a fabulous opportunity for GP to take the first step into international marketplace. And we are more confident to exploit U.S. markets”, stated Min Zhao, President (China). “We have already employed American staff to come into contact with main distributors and health product suppliers in the U.S. The U.S. market of raw material has a wide prospect”, added Feng Yu, General Manager of GP.

The aim of GP is to building a strategic and cooperative alliance with main distributors of health product and raw material in North America, to set up our own distribution network of health product and raw material, and to establish cooperative relationship with A-list manufacturers of health product andconsumption goods such as GNC, Coca Cola and Natures Bounty.

“Our team is working hard to break ground in the US, and then furthering into all major health marketplace. Our organic growth strategy is to expand internationally with more line ups of innovative, high demand and high profit products. We are seeing a continued increase in the consumption of organic and health products and we intend to take advantage of this,” stated ONE’s CEO Marius Silvasan. “Our growth strategy is based on continued organic growth coupled with strategic acquisitions of high margin/high profit companies in the organic products and natural and health supplements segments,” added Silvasan.

[jmurfk]

Website link fixed.

[Huggy Bear]

Yeah yeah, but I was hoping to find one in English since they trade on a US listed exchange... Perhaps in the future, doesnt affect my take on the potential here, just needs more eyes and exposure and volume... Rather new still, and rather lucrative IMO. Trading at 2x earnings, and not shabby earnings either. Hope to get in before next Q which may put up some even better numbers, it appears that like the stock itself, the company is just beginning to get real exposure and market share.

malc

[jmurfk]

That and other company info is in the ibox.

[Huggy Bear]

Does anyone know if Green Planet has a website? Thanks.

[jmurfk]

I took a position after the annual report. Very impressive for a stock under $3.00 a share IMO. .27 EPS is crazy for a stock trading .60.

[Huggy Bear]

Doing my weekend DD on green planet, and although this is perhaps a cheesy name for american investors, this company seems like the real deal. I cant find anything at all not to like so far, and this seems like a nice place to park some nice BFAR gains...

malc

[jmurfk]

Trading at 2X annual EPS is a joke. Company reporting very nice bottom lines, and the Q is just around the corner.

[joenatural]

Current P/E of 1.85 at today's closing price of .50 and what do I like most about GPLB ? They make CoQ10, a hugely popular drug in the USA. My dad takes CoQ10 every day since suffering severe side effects from Lipitor. Absolutely reversed all the side effects and he's always telling everybody about CoQ10. He calls it his "Wonder Drug." Cracks me up.

[jmurfk]

Q out any day now. Should have some very nice numbers after the .27 EPS annual report.

[jmurfk]

I'll do, some great potential in the one.

[AliAngel]

Hey J I saw that and I do like the dime for the quarter if not the first by the second quarter this year.
Keep us updated for sure.
Dave

[jmurfk]

Looking at the past Q, .10 is a good chance on the next Q. Positive EPS on the last 3 Qs, in the 5-7 cent range, 27 for the year.

[jmurfk]

.27 EPS on the 10-k for the period ending 31dec09. Also overc$1 per share stockholder equity. The 10k was very impressive. It popped the day after release, but fizzled. Amazed it's not higher. Just one of those under the radar stocks that will have it's day. Meanwhile, I stay on bid, lol.

[AliAngel]

Hey J I ran out of posts but I mentioned this on the phone to Brian in Florida.
Great stock and the fillings are just f ing awesome here.
I am looking for more bettween here and may as the 10q comes out.
Mark my post as I seem close to if not a .10 proffit here. We will see when the q comes.
Keep up the great picks and hold this one tight.
Dave

[jmurfk]

94% of the OS held by insiders, per the 10-K last week.

Approx OS around 25Mil as of March 26th, 2010:

The following table sets forth information as of March 26, 2010, with respect to the beneficial ownership of the common stock by (i) each director and officer of the Company, (ii) all directors and officers as a group, and (iii) each person known by the Company to own beneficially 5% or more of the common stock:


Name Beneficial Ownership (1) Percentage of Class (%)
One Bio, Corp 20,881,399 82.67%
Min Zhao 1,632,150 6.46%
Min Yan Zheng 1,216,183 4.81%
Shanyuan Ou 30,000 0.12%

All Directors and Executive Officers (3 persons) 2,878,333 11.39%

[jmurfk]

GPLB PR That many appeared to miss last week

Green Planet Reports Fourth Quarter and Full Year 2009 Results


Q4 Revenue, Operating Income and Net Income Increase 85%, 150% and 176% Respectively

MIAMI, FL, Mar 31, 2010 (MARKETWIRE via COMTEX) -- Green Planet Bioengineering Co., Ltd. (OTCBB: GPLB) ("Green Planet" or the "Company"), a bioengineering subsidiary of ONE Bio, Corp. (OTCBB: ONBI) that produces high quality health supplements and organic fertilizers and pesticides using green processes, reports fourth quarter and full year 2009 results.
Fourth Quarter and Full Year Results: Fourth quarter 2009 revenue was up 85% to $5,367,906 compared to $2,900,245 for the same period a year ago. Operating Income was up 150% to $2,458,289 compared to $984,677 for the same period last year. Net Income was up 176% to $1,785,618 compared to $647,590 for the same quarter last year. Earnings per share for the fourth quarter of 2009 reached $0.10 compared to $0.05 for the same period in 2008.

Full year 2009 revenue reached $13,297,616 compared to $10,401,530 for the 2008 fiscal period, an increase of 28%. Full year 2009 operating income and net income reached $5,941,181 and $4,318,399 respectively compared to $4,651,796 and $3,350,299 respectively for fiscal 2008, an increase of 28% and 29%. Earnings per share for 2009 reached $0.27 compared to $0.24 for fiscal 2008.



Three months ended Twelve months ended
31-Dec 31-Dec
----------------------- -----------------------
2009 2008 2009 2008
Sales revenue 5,367,906 2,900,245 13,297,616 10,401,530
Cost of sales (2,133,988) (520,256) (5,553,342) (3,939,610)
----------- ----------- ----------- -----------
Gross profit 3,233,918 1,848,884 7,744,274 6,461,920
----------- ----------- ----------- -----------
Operating expenses
Administrative expenses 238,585 522,565 947,251 1,117,729
R&D 178,833 278,103 378,497 444,404
Selling expenses 358,211 63,539 477,345 247,991
----------- ----------- ----------- -----------
775,629 864,207 1,803,093 1,810,124
----------- ----------- ----------- -----------
Income from operations 2,458,289 984,677 5,941,181 4,651,796
Other income/(Expense) (65,267) (14,618) (129,227) (78,578)
Income taxes (607,404) (336,768) (1,493,555) (1,222,919)
----------- ----------- ----------- -----------
Net income 1,785,618 647,590 4,318,399 3,350,299
=========== =========== =========== ===========

"We are pleased with our fourth quarter and full year results. The launch during the fourth quarter of our over the counter health product line and increased demand for our 5-HTP extract contributed to the increase in revenue and net income. We intend to increase distribution in China and abroad of our over the counter health product line in 2010," stated Min Zhao, Company CEO. "We are well positioned with a wide product portfolio to increase our performance in 2010," added Mr. Zhao.

About Green Planet;
Green Planet Bioengineering Co., Ltd. ("Green Planet") (http://www.greenplanetbio.com) (OTCBB: GPLB), a subsidiary of ONE Bio, Corp. (OTCBB: ONBI), is a high-tech bioengineering enterprise that engages in research & development, production and sale of various extracts from tobacco leaves' residues destined for health supplements and organic agricultural products. Green Planet is headquartered in Miami, FL with its main operation located in Sanming and Fuzhou, China. Since founded in 2005, Green Planet offers a full range of high quality bio-ecological products which include raw chemical materials such as CoQ10 and Solanesol, organic fertilizers and pesticides and organic health nutrients and supplements. Company's unique position in the bioengineering industry comes from its R&D using patented cutting-edge methods to create abundant downstream products ranging from plant indigenous medicine, pharmaceutical intermediates to a long list of eco-friendly products.

[jmurfk]

Fell back a bit, but will slowly move up over time IMO.

[jmurfk]

24,500 shares where traded between July 14th 2009 and March 30, 2009. Yesterday 29,000 traded. Most of the significant trades the last 9 months were around a $1.00. Only a few whack trades under a dollar. The last PPS of .15 at the open yesterday morning was a 100 share whack from march 8th. It had been a dollar previously. I don't have a forecast other than much higher than here, lol. Just getting discovered.

[Trend_Trader]

Agree so you tell me what price should GPLB be today based on eps / assets? THen tell me your price for 2010. taking the growth in rev and eps and giving it a fair expansion of 30-50% qoq growth. I take the 30-50% qoq growth from the Q3 to Q4 2009 jump in revs and net due to the new products that are in demand per the report!!! Now consider the float of 4 mil only and the MM will take this as high as they want. $15-$25 seems topps with the 20 mil OS.

[jmurfk]

When I saw the 10-K Tues night I was blown away. Very happy with my .53s off the first trade yesterday morning. Seems they have it going on quite well. I think some other folks realized it late day, when 10K traded over the last hour in the mid $1 range. Current price is less than 6X earnings. You have to like the $1 per share stickholder equity also.

[Trend_Trader]

They made .27 cents for 2009, PE now is really only 5 at $1.50 This stock should be trading near $5 now, forward eps looks to be .60+ if they can keep up the pace from Q4 2009 which they can due to the news products and demand for 5-HTP that were launched in Q4 2009. Rev and profits increased bigtime from Q3 2009 to Q4 2009 due to the new products $2 mil rev increase and 800K Net income increase. 4 mil float 20 mil OS here and ONBI owns like 80% of GPLB. See you at $20+ in the near future.

[jmurfk]

The OS is very small in this one. In the last hour or so of trading some large blocks went off in the dollar range. It may see some whacks, but further out, this should rest over $2. At that point, it's at 8x current earnings. Not to mention the economy is looking brighter. Good chance they continue the uptrend. A few smart traders picked up some .15s over the past months. Paid off for them yesterday.

[AUminer]

Tomorrow will be Interesting. Let's see how much "Follow Thru" there is. Very Good that there was very little Selling. Seems to Prove that Miniscule Float; and Belief in the Future.

[jmurfk]

Some heavy hitters came in the last hour and a half. 10K traded and brought the 1.74 up.

[jmurfk]

Thinking the same. Barely any shares here under $1.00 in the past.

[AUminer]

Hugh Potential Here. That 900% Up will "Draw a Little Attention"!!!

[jmurfk]

I posted the 10-K in the ibox. .27 EPS for the year. Opened at .53. The company also has over $1 equity per share.

[Militia Man]

New board.. whats good? Are we looking toward some growth?

Prisoner